loadpatents
Patent applications and USPTO patent grants for Heffron; Timothy.The latest application filed is for "cinnoline compounds and uses thereof".
Patent | Date |
---|---|
Cinnoline Compounds And Uses Thereof App 20220073520 - Malhotra; Sushant ;   et al. | 2022-03-10 |
Isoquinoline Compounds For The Treatment Of Cancer App 20210332064 - Liang; Jun ;   et al. | 2021-10-28 |
Azaindoles As Inhibitors Of Hpk1 App 20210299110 - HEFFRON; Timothy ;   et al. | 2021-09-30 |
Naphthyridine Compounds And Uses Thereof App 20210277024 - Kellar; Terry ;   et al. | 2021-09-09 |
Isoquinoline Compounds And Uses Thereof App 20210253580 - Liang; Jun ;   et al. | 2021-08-19 |
Naphthyridines as inhibitors of HPK1 Grant 11,034,692 - Chan , et al. June 15, 2 | 2021-06-15 |
Isoquinolines As Inhibitors Of Hpk1 App 20210163417 - Chan; Bryan ;   et al. | 2021-06-03 |
Azaindoles as inhibitors of HPK1 Grant 10,952,995 - Heffron , et al. March 23, 2 | 2021-03-23 |
8-aminoisoquinoline Compounds And Uses Thereof App 20200108075 - LIANG; Jun ;   et al. | 2020-04-09 |
Azaindoles As Inhibitors Of Hpk1 App 20200000780 - HEFFRON; Timothy ;   et al. | 2020-01-02 |
Tricyclic P13k Inhibitor Compounds And Methods Of Use App 20190330235 - Dotson; Jennafer ;   et al. | 2019-10-31 |
Naphthyridines as inhibitors of HPK1 Grant 10,407,424 - Chan , et al. Sept | 2019-09-10 |
Isoquinolines As Inhibitors Of Hpk1 App 20180282282 - Chan; Bryan ;   et al. | 2018-10-04 |
Naphthyridines As Inhibitors Of Hpk1 App 20180282328 - Chan; Bryan ;   et al. | 2018-10-04 |
Azaindazole compounds as inhibitors of T790M containing EGFR mutants Grant 9,951,064 - Bryan , et al. April 24, 2 | 2018-04-24 |
Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutants Grant 9,890,152 - Bryan , et al. February 13, 2 | 2018-02-13 |
Tricyclic P13k Inhibitor Compounds And Methods Of Use App 20170233407 - Dotson; Jennafer ;   et al. | 2017-08-17 |
Benzoxazepin PI3K inhibitor compounds and methods of use Grant 9,670,228 - Blaquiere , et al. June 6, 2 | 2017-06-06 |
Benzoxazepin Pi3k Inhibitor Compounds And Methods Of Use App 20170081341 - Blaquiere; Nicole ;   et al. | 2017-03-23 |
Tricyclic PI3K inhibitor compounds and methods of use Grant 9,546,182 - Dotson , et al. January 17, 2 | 2017-01-17 |
Benzoxazepin PI3K inhibitor compounds and methods of use Grant 9,546,178 - Blaquiere , et al. January 17, 2 | 2017-01-17 |
Azaindazole Compounds As Inhibitors Of T790m Containing Egfr Mutants App 20160257682 - Bryan; Marian C. ;   et al. | 2016-09-08 |
Benzoxazepin Pi3k Inhibitor Compounds And Methods Of Use App 20160052933 - Blaquiere; Nicole ;   et al. | 2016-02-25 |
Aminopyrimidine Compounds As Inhibitors Of T790m Containing Egfr Mutants App 20160016948 - Bryan; Marian C. ;   et al. | 2016-01-21 |
Bicyclic pyrazole LRRK2 small molecule inhibitors Grant 9,212,186 - Baker-Glenn , et al. December 15, 2 | 2015-12-15 |
Benzoxazepin PI3K inhibitor compounds and methods of use Grant 9,198,918 - Blaquiere , et al. December 1, 2 | 2015-12-01 |
Benzoxepin PI3K inhibitor compounds and methods of use Grant 9,175,009 - Blaquiere , et al. November 3, 2 | 2015-11-03 |
Benzoxazepin compounds selective for PI3K P110 delta and methods of use Grant 9,090,628 - Heffron , et al. July 28, 2 | 2015-07-28 |
Benzoxepin Pi3k Inhibitor Compounds And Methods Of Use App 20150094347 - Blaquiere; Nicole ;   et al. | 2015-04-02 |
Tricyclic P13k Inhibitor Compounds And Methods Of Use App 20150079081 - Dotson; Jennafer ;   et al. | 2015-03-19 |
Bicyclic Pyrazole Lrrk2 Small Molecule Inhibitors App 20150051201 - Baker-Glenn; Charles ;   et al. | 2015-02-19 |
Benzoxepin PI3K inhibitor compounds and methods of use Grant 8,952,043 - Blaquiere , et al. February 10, 2 | 2015-02-10 |
Tricyclic PI3K inhibitor compounds and methods of use Grant 8,883,799 - Dotson , et al. November 11, 2 | 2014-11-11 |
Benzoxazepin Pi3k Inhibitor Compounds And Methods Of Use App 20140288047 - Blaquiere; Nicole ;   et al. | 2014-09-25 |
Benzoxazepin PI3K inhibitor compounds and methods of use Grant 8,785,626 - Blaquiere , et al. July 22, 2 | 2014-07-22 |
Benzoxepin Pi3k Inhibitor Compounds And Methods Of Use App 20140135308 - Blaquiere; Nicole ;   et al. | 2014-05-15 |
Benzoxepin PI3K inhibitor compounds and methods of use Grant 8,673,952 - Blaquiere , et al. March 18, 2 | 2014-03-18 |
Benzoxazepin Pi3k Inhibitor Compounds And Methods Of Use App 20140058098 - Blaquiere; Nicole ;   et al. | 2014-02-27 |
Pyrazolopyridine PI3K inhibitor compounds and methods of use Grant 8,653,098 - Dotson , et al. February 18, 2 | 2014-02-18 |
Benzoxazepin PI3K inhibitor compounds and methods of use Grant 8,586,574 - Blaquiere , et al. November 19, 2 | 2013-11-19 |
Benzoxazepin Pi3k Inhibitor Compounds And Methods Of Use App 20130079331 - Blaquiere; Nicole ;   et al. | 2013-03-28 |
Benzoxepin Pi3k Inhibitor Compounds And Methods Of Use App 20130012488 - Blaquiere; Nicole ;   et al. | 2013-01-10 |
Benzoxazepin PI3K inhibitor compounds and methods of use Grant 8,343,955 - Blaquiere , et al. January 1, 2 | 2013-01-01 |
Benzoxazepin Compounds Selective For Pi3k P110 Delta And Methods Of Use App 20120245144 - Heffron; Timothy ;   et al. | 2012-09-27 |
Benzoxazepin Pi3k Inhibitor Compounds And Methods Of Use App 20120244149 - Blaquiere; Nicole ;   et al. | 2012-09-27 |
Benzoxepin PI3K inhibitor compounds and methods of use Grant 8,263,633 - Blaquiere , et al. September 11, 2 | 2012-09-11 |
Benzoxazepin P13K inhibitor compounds and methods of use Grant 8,242,104 - Blaquiere , et al. August 14, 2 | 2012-08-14 |
Tricyclic Pi3k Inhibitor Compounds And Methods Of Use App 20120171199 - Dotson; Jennafer ;   et al. | 2012-07-05 |
Pyrazolopyridine Pi3k Inhibitor Compounds And Methods Of Use App 20120035208 - Dotson; Jennafer ;   et al. | 2012-02-09 |
Benzoxepin Pi3k Inhibitor Compounds And Methods Of Use App 20110076291 - Blaquiere; Nicole ;   et al. | 2011-03-31 |
Benzoxazepin Pi3k Inhibitor Compounds And Methods Of Use App 20110076292 - Blaquiere; Nicole ;   et al. | 2011-03-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.